The growth of human atherosclerosis: Cell proliferation and collagen synthesis

Cardiovascular Pathology

Volumn 6, Issue 2, 1997, Pages 103-116

  Gordon, David ^a   Rekhter, Mark D ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR;

ANGIOGENESIS; ATHEROSCLEROSIS; CELL PROLIFERATION; COLLAGEN SYNTHESIS; CONFERENCE PAPER; HUMAN; PRIORITY JOURNAL;

EID: 0030982984     PISSN: 10548807     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1054-8807(96)00088-9     Document Type: Conference Paper

References (205)

1. McGill HC. Persistent problems in the pathogenesis of atherosclerosis. Arteriosclerosis 1984;4:443-451.
2. Stary HC. The sequence of cell and matrix changes in atherosclerotic lesions of coronary arteries in the first forty years of life. Eur Heart J 1990;11(suppl E):3-19.
3. Davies MJ, Woolf N. Atherosclerosis: what is it and why does it occur? Br Heart J 1993;69(suppl):S3-S11.
4. Wight TN. The vascular extracellular matrix. In Fuster V, Ross R, Topol EJ, eds. Atherosclerosis and Coronary Artery Disease. Philadelphia: Lippincott-Raven, 1996;421-440.
5. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993;362:801-809.
6. French JE. Atherosclerosis in relation to the structure and function of the arterial intima, with special reference to the endothelium. Int Rev Exp Pathol 1966;5:253.
7. Benditt EP. Origins of human atherosclerotic plaques: the role of altered gene expression. Arch Pathol Lab Med 1988;112:997-1001.
8. Ross R. The pathogenesis of atherosclerosis - an update. N Engl J Med 1986;314:488-500.
9. Velican C, Velican D. Natural history of coronary atherosclerosis as related to age. In Velican C, Velican D, eds. Natural History of Coronary Atherosclerosis. Boca Raton, FL: CRC Press, 1989;279-352.
10. Stary HC. Evolution and progression of atherosclerotic lesions in coronary arteries of children and young adults. Arteriosclerosis 1989; 9(suppl I):I-19-I-32.
11. Sims FH, Gavin JB. The early development of intimal thickening of human coronary arteries. Cor Artery Dis 1990;1:205-213.
12. Wilcox JN, Smith KM, Williams LT, Schwartz SM, Gordon D. Platelet-derived growth factor mRNA detection in human atherosclerotic plaques by in situ hybridization. J Clin Invest 1988;82:1134-1143.
13. Barrett TB, Benditt EP. Platelet-derived growth factor gene expression in human atherosclerotic plaques and normal artery wall. Proc Natl Acad Sci USA 1988;85:2810-2814.
14. Ross R, Masuda J, Raines EW, Gown AM, Katsuda S, Sasahara M, Maiden LT, Masuko H, Sato H. Localization of PDGF-B protein in macrophages in all phases of atherogenesis. Science 1990;248:1009-1012.
15. Ross R. Polypeptide growth factors and atherosclerosis. Trends Cardiovasc Med 1991;1:277-282.
16. Lindner V, Lappi DA, Baird A, Majack RA, Reidy MA. Role of basic fibroblast growth factor in vascular lesion formation. Circ Res 1991;68: 106-113.
17. Lindner V, Reidy MA. Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor. Proc Natl Acad Sci USA 1991;88:3739-3743.
18. Isik FF, Valentine HA, McDonald TO, Baird A, Gordon D. Localization of bFGF in human transplant coronary atherosclerosis. Ann NY Acad Sci 1991;638:487-488.
19. Brogi E, Winkles JA, Underwood R, Clinton SK, Alberts GF, Libby P. Distinct patterns of expression of fibroblast growth factors and their receptors in human atheroma and nonatherosclerotic arteries: association of acidic FGF with plaque microvessels and macrophages. J Clin Invest 1993;92:2408-2418.
20. Ferns GAA, Raines EW, Sprugel KH, Motani AS, Reidy MA, Ross R. Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF. Science 1991;253:1129-1132.
21. Schwartz SM, Murry CE, O'Brien ER. Vessel wall response to injury. Sci Med 1996;3:12-21.
22. Jawien A, Bowen-Pope DF, Lindner V, Schwartz SM, Clowes AW. Platelet-derived growth factor promotes smooth muscle migration and intimal thickening in a rat model of balloon angioplasty. J Clin Invest 1992;89:507-511.
23. Olson NE, Chao S, Lindner V, Reidy MA. Intimal smooth muscle cell proliferation after balloon catheter injury: The role of basic fibroblast growth factor. Am J Pathol 1992;140:1017-1023.
24. McBride W, Lange RA, Hillis LD. Restenosis after successful coronary angioplasty. Pathophysiology and prevention. N Engl J Med 1988;318:1734-1737.
25. Liu MW, Berk BC. Restenosis following coronary balloon angioplasty: role of smooth muscle cell proliferation. Trends Cardiovasc Med 1991;1:107-111.
26. Waller BF. Crackers, breakers, stretchers, drillers, scrapers, shavers, burners, welders, and melters - the future treatment of atherosclerotic coronary artery disease? A clinical-morphologic assessment. J Am Coll Cardiol 1989;13:969-987.
27. French BN, Rewcastle NB. Sequential morphological changes at the site of carotid endarterectomy. J Neurosurg 1974;41:745-754.
28. Spagnoli LG, Villaschi S, Neri L, Palmieri G, Taurino M, Faraglia V, Fiorani P. Autoradiographic studies of the smooth muscle cells in human arteries. Paroi Artérielle/Arterial Wall 1981;7:107-112.
29. Villaschi S, Spagnoli LG: Autoradiographic and ultrastructural studies on the human fibro-atheromatous plaque. Atherosclerosis 1983; 48:95-100.
30. Kamel OW, Franklin WA, Ringus JC, Meyer JS. Thymidine labeling index and Ki-67 growth fraction in lesions of the breast. Am J Pathol 1989;134:107-113.
31. Clowes AW, Reidy MA, Clowes MM. Kinetics of cellular proliferation after arterial injury. I. Smooth muscle growth in the absence of endothelium. Lab Invest 1983;49:327-333.
32. Walker LN, Reidy MA, Bowyer DE: Morphology and cell kinetics of fatty streak lesion formation in the hypercholesterolemic rabbit. Am J Pathol 1986;125:450-459.
33. Rosenfeld ME, Ross R. Macrophage and smooth muscle cell proliferation in atherosclerotic lesions of WHHL and comparably hypercholesterolemic fat-fed rabbits. Arteriosclerosis 1990;10:680-687.
34. Florentin RA, Nam SC, Daud AS, Jones R, Scott RF, Morrison ES, Kim DN, Lee KT, Thomas WA, Dodds WJ, Miller KD. Dietary-induced atherosclerosis in miniature swine. I-V. Exp Molec Path 1968;8:263-301.
35. Kim DN, Schmee J, Ho HT, Thomas WA. The "turning off" of excessive cell replicative activity in advanced atherosclerotic lesions of swine by a regression diet. Atherosclerosis 1988;71:131-142.
36. Orekhov AN, Kosykh VA, Repin VS, Smirnov VN. Cell proliferation in normal and atherosclerotic human aorta. I. Flow cytofluorometric determination of cellular deoxyribonucleic acid content. Lab Invest 1983;48:395-398.
37. Meyer JS, Nauert J, Koehm S, Hughes J. Cell kinetics of human tumors by in vitro bromodeoxyuridine labeling. J Histochem Cytochem 1989;37:1449-1454.
38. Celis JE, Fey SJ, Larsen PM, Celis A. Expression of the transformation-sensitive protein "cyclin" in normal human epidermal basal cells and simian virus 40-transformed keratinocytes. Proc Natl Acad Sci USA 1984;81:3128-3132.
39. Mathews MB, Bernstein RM, Franza BR, Garrels JI. Identity of the proliferating cell nuclear antigen and cyclin. Nature 1984;309:374-376.
40. Bravo R, Frank R, Blundell PA, Macdonald-Bravo H. Cyclin/PCNA is the auxiliary protein of DNA polymerase-d. Nature 1987;327:515-517.
41. Prelich G, Tan C, Kostura M, Mathews MB, So AG, Downey KM, Stillman B: Functional identity of proliferating cell nuclear antigen and a DNA polymerase-d auxiliary protein. Nature 1987;326:517-520.
42. Ogata K, Kurki P, Celis JE, Nakamura RM, Tan EM: Monoclonal antibodies to a nuclear protein (PCNA/Cyclin) associated with DNA replication. Exp Cell Res 1987;168:475-486.
43. Bravo R, Macdonald-Bravo H. Existence of two populations of cyclin/proliferating cell nuclear antigen during the cell cycle: association with DNA replication sites. J Cell Biol 1987;105:1549-1554.
44. Kurki P, Ogata K, Tan EM. Monoclonal antibodies to proliferating cell nuclear antigen (PCNA)/cyclin as probes for proliferating cells by immunofluorescence microscopy and flow cytometry. J Immuno Methods 1988;109:49-59.
45. Cellis JE, Madsen P, Nielsen S, Celis A. Nuclear patterns of cyclin (PCNA) antigen distribution subdivide S-phase in cultured cells - some applications of PCNA antibodies. Leukemia Res 1986;10:237-249.
46. Travali S, Ku D, Rizzo MG, Ottavio L, Baserga R, Calabretta B. Structure of the human gene for the proliferating cell nuclear antigen. J Biol Chem 1989;264:7466-7472.
47. Zuber M, Tan EM, Ryoji M. Involvement of proliferating cell nuclear antigen (cyclin) in DNA replication in living cells. Mol Cell Biol 1989;9:57-66.
48. Celis JE, Celis A. Cell cycle-dependent variations in the distribution of the nuclear protein cyclin proliferating cell nuclear antigen in cultured cells: subdivision of S phase. Proc Natl Acad Sci USA 1985;82:3262-3266.
49. Bravo R. Synthesis of the nuclear protein cyclin (PCNA) and its relationship with DNA replication. Exp Cell Res 1986;163:287-293.
50. Kurki P, Vanderlaan M, Dolbeare F, Gray J, Tan EM. Expression of proliferating cell nuclear antigen (PCNA)/Cyclin during the cell cycle. Exp Cell Res 1986;166:209-219.
51. Gordon D, Reidy MA, Benditt EP, Schwartz SM: Cell proliferation in human coronary arteries. Proc Natl Acad Sci USA 1990;87:4600-4604.
52. Hall PA, Levison DA, Woods AL, Yu CCW, Kellock DB, Watkins JA, Barnes DM, Gillett CE, Camplejohn R, Dover R, Waseem NH, Lane DP. Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol 1990;162:285-294.
53. van Dierendonck JH, Wijsman JH, Keijzer R, van de Velde CJH, Cornelisse CJ. Cell-cycle-related staining patterns of anti-proliferating cell nuclear antigen monoclonal antibodies: comparison with Brd-Urd labelling and Ki-67 staining. Am J Pathol 1991;138:1165-1172.
54. Landberg G, Roos G. Antibodies to proliferating cell nuclear antigen as S-phase probes in flow cotometric cell cycle analysis. Cancer Res 1991;51:4570-4574.
55. Gelb AB, Kamel OW, LeBrun DP, Warnke RA. Estimation of tumor growth fractions in archival formalin-fixed, paraffin-embedded tissues using two anti-PCNA/cyclin monoclonal antibodies: factors affecting reactivity. Am J Pathol 1992;141:1453-1458.
56. Kurki P, Lotz M, Ogata K, Tan EM. Proliferating cell nuclear antigen (PCNA)/cyclin in activated human T lymphocytes. J Immunol 1987; 138:4114-4120.
57. Toschi L, Bravo R. Changes in cyclin/proliferating cell nuclear antigen distribution during DNA repair synthesis. J Cell Biol 1988; 107:1623-1628.
58. Moore KS, Sullivan K, Tan EM, Prystowsky MB. Proliferating cell nuclear antigen/cyclin is an interleukin 2-responsive gene. J Biol Chem 1987;262:8447-8450.
59. Isik FF, Ferguson M, Yamanaka E, Gordon D. Proliferating cell nuclear antigen: a marker for cell proliferation in autopsy tissues. Arch Pathol Lab Med 1992;116:1142-1146.
60. Mercer WE, Avignolo C, Baserga R. Role of the p53 protein in cell proliferation as studied by microinjection of monoclonal antibodies. Mol Cell Biol 1984;4:276-281.
61. Cattoretti G, Becker MHG, Key G, Duchrow M, Schlüter C, Galle J, Gerdes J: Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 1992;168:357-363.
62. Chou MY, Chang ALC, McBride J, Donoff B, Gallagher GT, Wong DTW: A rapid method to determine proliferation patterns of normal and malignant tissues by H3 mRNA in situ hybridization. Am J Pathol 1990;136:729-733.
63. Rekhter MD, Gordon D. Active proliferation of different cell types, including lymphocytes, in human atherosclerotic plaques. Am J Pathol 1995;147:668-677.
64. Sims FH. A comparison of coronary and internal mammary arteries and implications of the results in the etiology of arteriosclerosis. Am Heart J 1983;105:560-566.
65. Hartman JD. Structural changes within the media of coronary arteries related to intimal thickening. Am J Pathol 1977;89:13-34.
66. Velican C, Velican D. Intimal thickening in developing coronary arteries and its relevance to atherosclerotic involvement. Atherosclerosis 1976;23:345-355.
67. Jaeger E, Rust S, Roessner A, Kleinhans G, Buchholz B, Althaus M, Rauterberg J, Gerlach U. Joint occurrence of collagen mRNA containing cells and macrophages in human atherosclerotic vessels. Atherosclerosis 1991;31:55-68.
68. Katsuda S, Coltrera MD, Ross R, Gown AM. Human atherosclerosis: IV. Immunocytochemical analysis of cell activation and proliferation in lesions of young adults. Am J Pathol 1993;142:1787-1793.
69. O'Brien ER, Alpers CE, Stewart DK, Ferguson M, Tran N, Gordon D, Benditt EP, Hinohara T, Simpson JB, Schwartz SM. Proliferation in primary and restenotic coronary atherectomy tissue: Implications for antiproliferative therapy. Circ Res 1993;73:223-231.
70. Jahn L, Kreuzer J, von Hodenberg E, Kübler W, Franke WW, Allenberg J, Izumo S. Cytokeratins 8 and 18 in smooth muscle cells: detection in human coronary artery, peripheral vascular, and vein graft disease and in transplantation-associated arteriosclerosis. Arterioscl Thromb 1993;13:1631-1639.
71. Taylor AJ, Farb AA, Angello DA, Burwell LR, Virmani R. Proliferative activity in coronary atherectomy tissue: clinical, histopathologic, and immunohistochemical correlates. Chest 1995;108:815-820.
72. Bresciani F, Paoluzi R, Benassi M, Nervi C, Casale C, Ziparo E. Cell kinetics and growth of squamous cell carcinomas in man. Cancer Res 1974;34:2405-2415.
73. Kim DN, Schmee J, Lee KT, Thomas WA. Atherosclerotic lesions in the coronary arteries of hyperlipidemic swine. Part I. Cell increases, divisions, losses and cells of origin in first 90 days. Atherosclerosis 1987;64:231-242.
74. Kim DN, Imai H, Schmee J, Lee KT, Thomas WA. Initimal cell mass-derived atherosclerotic lesions in the abdominal aorta of hyperlipidemic swine. Part I. Cell of origin, cell divisions, and cell losses in the first 90 days on diet. Atherosclerosis 1985;56:169-188.
75. Scott RF, Thomas WA, Kim DN, Schmee J. Endothelial cell labelling indices in swine aortas in relation to intimal cell mass-derived atherosclerotic lesions. Atherosclerosis 1985;56:263-270.
76. Florentin RA, Nam SC, Lee KT, Lee KJ, Thomas WA. Increased mitotic activity in aortas of swine after three days of cholesterol feeding. Arch Path 1969;88:463-469.
77. Geer JC, McGill HC, Robertson WB, Strong JP. Histologic characteristics of coronary artery fatty streaks. Lab Invest 1968;18:565-570.
78. Roederer GO, Langlois YE, Jager KA, Primozich JF, Beach KW, Phillips DJ, Strandness DE. The natural history of carotid arterial disease in asymptomatic patients with cervical bruits. Stroke 1984;15:605-613.
79. DeBakey ME. Patterns of atherosclerosis and rates of progression. New York: Raven Press, 1978;1-56.
80. Brown BG, Lin JT, Kelsey S, Passamani ER, Levy RI, Dodge HT, Detre KM. Progression of coronary atherosclerosis in patients with probable familial hypercholesterolemia. Arteriosclerosis 1989;9(suppl I): I-81-I-90.
81. Brunel P, Bourassa MG, Wiseman A. Different rates of coronary artery disease progression in patients with normal and mildly diseased coronary arteries. Cor Artery Dis 1991;2:449-454.
82. Asdente M, Pavesi L, Oreste PL, Colombo A, Kuhn W, Tremoli E. Evaluation of atherosclerotic lesions using NMR microimaging. Atherosclerosis 1990;80:243-253.
83. Nelson JA, Yuan C, Hatsukami TS. MR cardiovascular imaging. Nature Med 1995;1:996-997.
84. 2-Weighted contrast for NMR characterization of human atherosclerosis. Arterioscler Thromb 1995;15:1533-1542.
85. Rekhter MD, Gordon D. Does PDGF A stimulate proliferation of arterial mesenchymal cells in human atherosclerotic plaques? Circ Res 1994;75:410-417.
86. Berk BC, Alexander RW, Brock TA, Gimbrone MA, Webb RC. Vasoconstriction: a new activity for platelet-derived growth factor. Science 1986;232:87-90.
87. Koyama N, Morisaki N, Saito Y, Yoshida S. Regulatory effects of platelet-derived growth factor-AA homodimer on migration of vascular smooth muscle cells. J Biol Chem 1992;267:22806-22812.
88. Hansson GK, Jonasson L, Holm J, Clowes MM, Clowes AW: G-Interferon regulates vascular smooth muscle proliferation and Ia antigen expression in vivo and in vitro. Circ Res 1988;63:712-719.
89. Edelman ER, Adams DH, Karnovsky MJ. Effect of controlled adventitial heparin delivery on smooth muscle cell proliferation following endothelial injury. Proc Natl Acad Sci USA 1990;87:3773-3777.
90. Garg UC, Hassid A. Nitric oxide-generating vasodilators and 8-bromocyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 1989; 83:1774-1777.
91. Taguchi J, Abe J, Okazaki H, Takuwa Y, Kurokawa K. L-arginine inhibits neointimal formation following balloon injury. Life Sci 1993; 53:PL-387-PL-392.
92. Sarkar R, Meinberg EG, Stanley JC, Gordon D, Webb RC. Nitric oxide reversibly inhibits the migration of cultured vascular smooth muscle cells. Circ Res 1996;78:225-230.
93. Billingham ME. Cardiac transplant atherosclerosis. Transplant Proc 1987;19:19-25.
94. Oguma S, Banner B, Zerbe T, Starzl T, Demetris AJ. Participation of dentritic cells in vascular lesions of chronic rejection of human allografts. Lancet 1988;Oct. 22:933-936.
95. Schoen FJ, Libby P. Cardiac transplant graft arteriosclerosis. Trends Cardiovasc Med 1991;1:216-223.
96. Gravanis MB. Allograft heart accelerated atherosclerosis: evidence for cell-mediated immunity in pathogenesis. Modern Pathol 1989;2: 495-505.
97. Libby P, Salomon RN, Payne DD, Schoen FJ, Pober JS. Functions of vascular wall cells related to development of transplantation-associated coronary arteriosclerosis. Transplant Proc 1989;21:3677-3684.
98. Cramer D. Graft Arteriosclerosis in Heart Transplantation. Austin, R.G. Landes, 1993;1-95.
99. Adams DH, Russell ME, Hancock WW, Sayegh MH, Wyner LR, Karnovsky MJ. Chronic rejection in experimental cardiac transplantation: studies in the Lewis-F344 model. Immunological Rev 1993;5-19.
100. Häyry P, Isoneimi H, Yilmaz S, Mennander A, Lemström K, Räisänen-Sokolowski A, Koskinen P, Ustinov P, Lautenschlager I, Taskinen E, Krogerus L, Aho P, Paavonen T. Chronic allograft rejection. Immunological Rev 1993;134:33-81.
101. Isik FF, McDonald TO, Ferguson M, Yamanaka E, Gordon D: Transplant arteriosclerosis in a rat aortic model. Am J Pathol 1992;141:1139-1149.
102. Mennander A, Tiisala S, Halttunen J, Yilmaz S, Paavonen T, Häyry P: Chronic rejection in rat aortic allografts: an experimental model for transplant arteriosclerosis. Arterioscl Thromb 1991;11:671-680.
103. Shi C, Russell ME, Bianchi C, Newell JB, Haber E. Murine model of accelerated transplant arteriosclerosis. Circ Res 1994;75:199-207.
104. Uretsky BF, Murali S, Reddy PS, Rabin B, Lee A, Griffith BP, Hardesty RL, Trento A, Bahnson HT. Development of coronary artery disease in cardiac transplant patients receiving immunosuppressive therapy with cyclosporine and prednisone. Circ 1987;76:827-834.
105. Gordon D, Alpers CE. Proliferation and growth factor expression in human transplant arteries. Lab Invest 1991;64:18a.
106. Waller BF. Pathology of transluminal balloon angioplasty used in the treatment of coronary heart disease. Hum Pathol 1987;18:476-484.
107. O'Malley MK. The development of intimal hyperplasia and its possible prevention. In Greenhalgh RM, Hollier LH, eds. The Maintenance of Arterial Reconstruction. London, Saunders, 1991;3-14.
108. Wilcox JN. Thrombin and other potential mechanisms underlying restenosis. Circ 1991;84:432-435.
109. Ueda M, Becker AE, Tsukada T, Numano F, Fujimoto T. Fibrocellular tissue response after percutaneous transluminal coronary angioplasty: an immunocytochemical analysis of the cellular composition. Circ 1991;83:1327-1332.
110. Walley VM, Byard RW, Keon WJ. A study of the sequential morphologic changes after manual coronary endarterectomy. J Thorac Cardiovasc Surg 1991;102:890-894.
111. Simpson JB, Selmon MR, Robertson GC, Cipriano PR, Hayden WG, Johnson DE, Fogarty TJ. Transluminal atherectomy for occlusive pe ripheral vascular disease. Am J Cardiol 1988;61:96g-101g.
112. Nobuyoshi M, Kimura T, Nosaka H, Mioka S, Ueno K, Yokoi H, Hamasaki N, Horiuchi H, Ohishi H. Restenosis after successful percutaneous transluminal coronary angioplasty: serial angiographic follow-up of 229 patients. J Am Coll Cardiol 1988;12:616-623.
113. Garratt KN, Holmes DR, Bell MR, Bresnahan JF, Kaufmann UP, Vlietstra RE, Edwards WD. Restenosis after directional coronary atherectomy: differences between primary atheromatous and restenosis lesions and influence of subintimal tissue resection. J Am Coll Cardiol 1990;16:1665-1671.
114. Popma JJ, Topol EJ. Factors influencing restenosis after coronary angioplasty. Am J Med 1990;88:16n-24n.
115. Serruys PW, Luijten HE, Beatt KJ, Geuskens R, de Feyter PJ, van den Brand M, Reiber JHC, ten Katen HJ, van Es GA, Hugenholtz PG. Incidence of restenosis after successful coronary angioplasty: a time-related phenomenon. Circulation 1988;77:361-371.
116. Pickering JG, Weir L, Jekanowski J, Kearney MA, Isner JM: Proliferative activity in peripheral and coronary atherosclerotic plaque among patients undergoing percutaneous revascularization. J Clin Invest 1993;91:1469-1480.
117. O'Brien ER, Schwartz SM. Update on the biology and clinical study of restenosis. Trends Cardiovasc Med 1993;
118. Nikol S, Isner JM, Pickering JG, Kearney M, Leclerc G, Weir L. Expression of transforming growth factor-b1 is increased in human vascular restenosis lesions. J Clin Invest 1992;90:1582-1592.
119. Orekhov AN, Karpova II, Tertov VV, Rudchenko SA, Andreeva ER, Krushinsky AV, Smirnov VN. Cellular composition of atherosclerotic and uninvolved human aortic subendothelial intima. Light-microscopic study of dissociated aortic cells. Am J Pathol 1984;115: 17-24.
120. Rekhter MD, Andreeva ER, Mironov AA, Orekhov AN. Three-dimensional cytoarchitecture of normal and atherosclerotic intima of human aorta. Am J Pathol 1991;138:569-580.
121. Swedberg SH, Brown BG, Sigley R, Wight TN, Gordon D, Nicholls SC. Intimal fibromuscular hyperplasia at the venous anastomosis of PTFE grafts in hemodialysis patients. Circulation 1989;80:1726-1736.
122. Giacchino JL, Geis WP, Buckingham JM, Vertuno LL, Bansal VK. Vascula access: long-term results, new techniques. Arch Surg 1979; 114:403-409.
123. Wilson SE. Complications of vascular access procedures. In Wilson SE, Owens ML, eds. Vascular Access Surgery. Chicago, Year Book Medical Publishers, 1980;185-207.
124. Adams MB, Johnson CP, Roza AM. Complications of vascular access. In Bernhard VM, Towne JB, eds. Complications in Vascular Surgery. St. Louis, Quality Medical Publishing, 1991;389-402.
125. Rekhter MD, Nicholls SC, Ferguson M, Gordon D. Cell proliferation in human arteriovenous fistulas used for hemodialysis. Arterioscl Thromb 1993;13:609-617.
126. Reidy MA. Proliferation of smooth muscle cells at sites distant from vascular injury. Arteriosclerosis 1990;10:298-305.
127. Hung DT, Vu TH, Nelken NA, Coughlin SR. Thrombin-induced events in non-platelet cells are mediated by the unique proteolytic mechanism established for the cloned platelet thrombin receptor. J Cell Biol 1992;116:827-832.
128. Spagnoli LG, Orlandi A, Santuesanio G. Foam cells of the rabbit atherosclerotic plaque arrested in metaphase by cholchicine show a macrophage phenotype. Atherosclerosis 1991;88:87-92.
129. Rosenfeld ME, Ylä-Herttuala S, Lipton BA, Ord VA, Witztum JL, Steinberg D. Macrophage colony-stimulating factor mRNA and protein in atherosclerotic lesions of rabbits and humans. Am J Pathol 1992;140:291-300.
130. Clinton SK, Underwood R, Hayes L, Sherman ML, Kufe DW, Libby P. Macrophage colony-stimulating factor gene expression in vascular cells and in experimental and human atherosclerosis. Am J Pathol 1992;140:301-316.
131. Murashima A, Takasaki Y, Ohgaki M, Hashimoto H, Shirai T, Hirose S. Activated peripheral blood mononuclear cells detected by murine monoclonal antibodies to proliferating cell nuclear antigen in active lupus patients. J Clin Immunol 1990;10:28-37.
132. Gabbiani G, Kocher O, Bloom WS, Vandekerckhove J, Weber K. Actin expression in smooth muscle cells of rat aortic intimal thickening, human atheromatous plaque, and cultured rat aortic media. J Clin Invest 1984;73:148-152.
133. Thyberg J, Nilsson J, Palmberg L, Sjölund M. Adult human arterial smooth muscle cells in primary culture. Modulation from contractile to synthetic phenotype. Cell Tissue Res 1985;239:69-74.
134. Campbell GR, Campbell JH, Manderson JA, Horrigan S, Rennick RE. Arterial smooth muscle: A multifunctional mesenchymal cell. Arch Pathol Lab Med 1988;112:977-986.
135. Babaev VR, Antonov AS, Zacharova OS, Romanov UA, Krushinsky AV, Tsibulsky VP, Shirinsky VP, Repin VS, Smirnov VN. Identification of intimal subendothelial cells from human aorta in primary culture. Atherosclerosis 1988;71:45-56.
136. Owens GK, Loeb A, Gordon D, Thompson MM. Expression of smooth muscle-specific a-isoactin in cultured vascular smooth muscle cells: relationship between growth and cytodifferentiation. J Cell Biol 1986;102:343-352.
137. Chamley-Campbell JH, Campbell GR, Ross R. Phenotype-dependent response of cultured aortic smooth muscle to serum mitogens. J Cell Biol 1981;89:379-383.
138. Zamir M, Silver MD. Vasculature in the walls of human coronary arteries. Arch Pathol Lab Med 1985;109:659-662.
139. Barger AC, Beeuwkes R, Lainey LL, Silverman KJ. Hypothesis: vasa vasorum and neovascularization of human coronary arteries. A possible role in the pathophysiology of atherosclerosis. N Engl J Med 1984;310:175-177.
140. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992;119:493-501.
141. Wijsman JH, Jonker RR, Keijzer R, van de Velde CJH, Cornelisse CJ, van Dierendonck JH. A new method to detect apoptosis in paraffin sections: in situ end-labeling of fragmented DNA. J Histochem Cytochem 1993;41:7-12.
142. Schwartz SM, Bennett MR. Death by any other name. Am J Pathol 1995;147:229-234.
143. Bochaton-Piallat M, Gabbiani F, Redard M, Desmouliere A, Gabbiani G. Apoptosis participates in cellularity regulation during rat aortic intimal thickening. Am J Pathol 1995;146:1059-1064.
144. Han DKM, Haudenschild CC, Hong MK, Tinkle BT, Leon MB, Liau G. Evidence for apoptosis in human atherogenesis and in a rat vascular injury model. Am J Pathol 1995;147:267-277.
145. Geng Y, Libby P. Evidence for apoptosis in human atheroma: colocalization with interleukin-1b-converting enzyme. Am J Pathol 1995;147: 251-266.
146. Wight TN. Cell biology of arterial proteoglycans. Arteriosclerosis 1989;9:1-20.
147. Mayne R. Collagenous proteins of blood vessels. Arteriosclerosis 1986;6:585-593.
148. Smith EB. The influence of age and atherosclerosis on the chemistry of aortic intima. J Atheroscler Res 1965;5:241-248.
149. Falk E. Plaque rupture with severe pre-existing stenosis precipitating coronary thrombosis: characteristics of coronary atherosclerotic plaques underlying fatal occlusive thrombi. Br Heart J 1983;50:127-134.
150. Constantinides P. Pathogenesis of cerebral artery thrombosis in man. Arch Pathol 1967;83:422-428.
151. Richardson PD, Davies MJ, Born GVR: Influence of plaque configuration and stress distribution on fissuring of coronary atherosclerotic plaques. Lancet 1989;October 21:941-944.
152. Burleigh MC, Briggs AD, Lendon CL, Davies MJ, Born GVR, Richardson PD. Collagen types I and III, collagen content, GAGs and mechanical strength of human atherosclerotic plaque caps: span-wise variations. Atherosclerosis 1992;96:71-81.
153. Ooshima A, Muragaki Y. Collagen metabolism in atherogenesis. Ann New York Acad Sci 1990;598:582-584.
154. Katsuda S, Okada Y, Minamoto T, Oda Y, Matsui Y, Nakanishi I. Collagens in human atherosclerosis: immunohistochemical analysis using collagen type-specific antibodies. Arterioscl Thromb 1992;12:494-502.
155. Shekhonin BV, Domogatsky SP, Muzykantov VR, Idelson GL, Rukosuev VS: Distribution of Type I, III, IV and V collagen in normal and atherosclerotic human arterial wall: immunomorphological characteristics. Coll Relat Res 1985;5:355-368.
156. Rauterberg J, Jaeger E. Collagen and collagen synthesis in the atherosclerotic vessel wall. In Robenek H, Severs NJ, eds. Cell Interactions in Atherosclerosis. Boca Raton, FL: CRC Press, 1992;101-135.
157. Ross R, Wight TN, Strandness E, Thiele B. Human atherosclerosis I. Cell constitution and characteristics of advanced lesions of the superficial femoral artery. Am J Pathol 1984;114:79-93.
158. Opsahl WP, DeLuca DJ, Ehrhart LA. Accelerated rates of collagen synthgesis in atherosclerotic arteries quantified in vivo. Arteriosclerosis 1987;7:470-476.
159. Fischer GM, Swain ML, Cherian K. Increased vascular collagen and elastin synthesis in experimental atherosclerosis in the rabbit. Atherosclerosis 1980;35:11-20.
160. McCullagh KG, Ehrhart LA. Increased arterial collagen synthesis in experimental canine atherosclerosis. Atherosclerosis 1974;19:13-28.
161. Clowes AW, Reidy MA, Clowes MM: Mechanisms of stenosis after arterial injury. Lab Invest 1983;49:208-215.
162. Snow AD, Bolender RP, Wight TN, Clowes AW. Heparin modulates the composition of the extracellular matrix domain surrounding arterial smooth muscle cells. Am J Pathol 1990;137:313-330.
163. Majesky MW, Lindner V, Twardzik DR, Schwartz SM, Reidy MA. Production of transforming growth factor beta 1 during repair of arterial injury. J Clin Invest 1991;88:904-910.
164. Amento EP, Ehsani N, Palmer H, Libby P. Cytokines and growth factors positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells. Arterioscl Thromb 1991;11:1223-1230.
165. Okada Y, Katsuda S, Matsui Y, Watanabe H, Nakanishi I. Collagen synthesis by cultured arterial smooth muscle cells during spontaneous phenotypic modulation. Acta Path Jap 1990;40:157-164.
166. Ang AA, Tachas G, Campbell JH, Bateman JF, Campbell GR: Collagen synthesis by cultured rabbit aortic smooth-muscle cells: alteration with phenotype. Biochem J 1990;265:461-469.
167. Crouch EC, Parks WC, Rosenbaum JL, Chang D, Whitehouse L, Wu L, Stenmark KR, Orton EC, Mecham RP. Regulation of collagen production by medial smooth muscle cells in hypoxic pulmonary hypertension. Am Rev Respir Dis 1989;140:1045-1051.
168. Sage H, Pritzl P, Bornstein P. Secretory phenotypes of endothelial cells in culture: comparison of aortic, venous, capillary, and corneal endothelium. Arteriosclerosis 1981;1:427-442.
169. Sumpio BE, Banes AJ, Link WG, Johnson G. Enhanced collagen production by smooth muscle cells during repetitive mechanical stretching. Arch Surg 1988;123:1233-1236.
170. Grande JP, Glagov S, Bates SR, Horwitz AL, Mathews MB. Effect of normolipemic and hyperlipemic serum on biosynthetic response to cyclic stretching of aortic smooth muscle cells. Arteriosclerosis 1989;9:446-452.
171. Tozzi CA, Poiani GJ, Harangozo AM, Boyd CD, Riley DJ: Pressure-induced connective tissue synthesis in pulmonary artery segments is dependent on intact endothelium. J Clin Invest 1989;84:1005-1012.
172. Kulik TJ, Alvarado SP. Effect of stretch on growth and collagen synthesis in cultured rat and lamb pulmonary arterial smooth muscle cells. J Cell Physiol 1993;157:615-624.
173. Lynch SE, Colvin RB, Antoniades HN. Growth factors in wound healing: Single and synergistic effects on partial thickness porcine skin wounds. J Clin Invest 1989;84:640-646.
174. Pierce GF. Macrophages: important physiologic and pathologic sources of polypeptide growth factors. Am J Respir Cell Mol Biol 1990;2:233-234.
175. Roberts AB, Heine UI, Flanders KC, Sporn MB. Transforming growth factor-b: major role in regulation of extracellular matrix. Ann N Y Acad Sci 1990;580:225-232.
176. Roberts AB, Sporn MB, Assoian RK, Smith JM, Roche NS, Wakefield LM, Heine UI, Liotta LA, Falanga V, Kehrl JH, Fauci AS. Transforming growth factor type b: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci USA 1986;83:4167-4171.
177. Bornstein P, Sage H. Regulation of collagen gene expression. Prog Nucleic Acid Res Mol Biol 1989;37:67-106.
178. Pierce GF, Mustoe TA, Senior RM, Reed J, Griffin GL, Thomason A, Deuel TF. In vivo incisional wound healing augmented by platelet-derived growth factor and recombinant c-sis gene homodimeric proteins. J Exp Med 1988;167:974-987.
179. Hansson GK, Holm J. Interferon-G inhibits arterial stenosis after injury. Circulation 1991;84:1266-1272.
180. Gown AM, Tsukada T, Ross R. Human atherosclerosis. II. Immunocytochemical analysis of the cellular composition of human atherosclerotic lesions. Am J Pathol 1986;125:191-207.
181. Jonasson L, Holm J, Skalli O, Bondjers G, Hansson GK. Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis 1986;6:131-138.
182. Hansson GK, Jonasson L, Seifert PS, Stemme S. Immune mechanisms in atherosclerosis. Arteriosclerosis 1989;9:567-578.
183. Hansson GK, Holm J, Holm S, Fotev Z, Hedrich H, Fingerle J. T lymphocytes inhibit the vascular response to injury. Proc Natl Acad Sci USA 1991;88:10530-10534.
184. Leibovich SJ, Ross R. The role of the macrophage in wound repair: a study with hydrocortisone and antimacrophage serum. Am J Pathol 1975;78:71-100.
185. Phan SH, Kunkel SL. Lung cytokine production in bleomycin-induced pulmonary fibrosis. Exp Lung Res 1992;18:29-43.
186. Karmiol S, Phan SH. Fibroblasts and cytokines. In Kunkel S, Remick D, eds. Cytokines in Health and Disease. New York: Marcel Dekker, 1992;271-296.
187. Riches DW. The multiple roles of macrohages in wound healing. In Clark RAF, Henson PM, eds. The Molecular and Cellular Biology of Wound Repair. New York. Plenum Press, 1988;213-239.
188. Bahadori L, Milder J, Gold L, Botney M. Active macrophage-associated TGF-b co-localizes with type I procollagen gene expression in atherosclerotic human pulmonary arteries. Am J Pathol 1995;146:1140-1149.
189. Botney MD, Liptay MJ, Kaiser LR, Cooper JD, Parks WC, Mecham RP. Active collagen synthesis by pulmonary arteries in human primary pulmonary hypertension. Am J Pathol 1993;143:121-129.
190. Rekhter MD, Zhang K, Narayanan AS, Phan S, Schork MA, Gordon D. Type I collagen gene expression in human atherosclerosis: localization to specific plaque regions. Am J Pathol 1993;143:1634-1648.
191. Jaeger E, Rust S, Scharffetter K, Roessner A, Winter J, Buchholz B, Althaus M, Rauterberg J. Localization of cytoplasmic collagen mRNA in human aortic coarctation: mRNA enhancement in high blood pressure-induced intimal and medial thickening. J Histochem Cytochem 1990;38:1365-1375.
192. Ziats NP, Robertson AL. Effects of peripheral blood monocytes on human vascular cell proliferation. Atherosclerosis 1981;38:401-410.
193. Libby P, Hansson GK. Involvement of the immune system in human atherogenesis: current knowledge and unanswered questions. Lab Invest 1991;64:5-15.
194. Cliff WJ, Heathcote CR, Moss NS, Reichenbach DD. The coronary arteries in cases of cardiac and noncardiac sudden death. Am J Pathol 1988;132:319-329.
195. High OBB, Adams CWM. The role of macrophages and giant cells in advanced human atherosclerosis. Atherosclerosis 1980;36:441-447.
196. Tsukada T, Kubota A, Ueda M, Amano J, Shimokado K, Numano F. Immunocytochemical analysis of the atherosclerotic lesion. Japan Circ J 1991;55:996-1002.
197. Rekhter MD, Gordon D: Cell proliferation and collagen synthesis are two independent events in human atherosclerotic plaques. J Vasc Res 1994;31:280-286.
198. Geiringer E. Intimal vascularisation and atherosclerosis. J Path Bact 1951;63:201-211.
199. Kamat BR, Galli SJ, Barger AC, Lainey LL, Silverman KJ. Neovascularization and coronary atherosclerotic plaque: cinematographic localization and quantitative histologic analysis. Hum Pathol 1987;18:1036-1042.
200. Wolinsky H, Glagov S. Nature of species differences in the medial distribution of aortic vasa vasorum in mammals. Circ Res 1967;20:409-421.
201. Fryer JA, Myers PC, Appleberg M. Carotid intraplaque hemorrhage: the significance of neovascularity. J Vasc Surg 1987;6:341-349.
202. Alpern-Elran H, Morog N, Robert F, Hoover G, Kalant N, Brem S. Angiogenic activity of the atherosclerotic carotid artery plaque. J Neurosurg 1989;70:942-945.
203. Strieter RM, Polverini PJ, Kunkel SL, Arenberg DA, Burdick MD, Kasper J, Dzuiba J, Damme JV, Walz A, Marriott D, Chan S, Roczniak S, Shanafelt AB. The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. J Biol Chem 1995;270:27348-27357.
204. Folkman J. Angiogenesis and cancer, vascular, rheumatoid and other disease. Nature Med 1995;1:27-31.
205. Nabel EG, Yang Z, Plautz G, Forough R, Zhan X, Haudenschild CC, Maciag T, Nabel GJ. Recombinant fibroblast growth factor-1 promotes intimal hyperplasia and angiogenesis in arteries in vivo. Nature 1993;362:844-846.